[
  "Mori Arkin got his start in business in 1972 helping his father run a small Israeli pharmaceutical distribution company. ",
  "The Arkins eventually moved into generic drug manufacturing, founding Agis Industries.",
  "In 2004, they sold Agis to U.S. pharmaceutical company Perrigo for $818 million in cash and stock. ",
  "Still bullish on healthcare, he oversaw a January 2018 public offering on Nasdaq of Sol-Gel Technologies, a dermatology company. He owns over 65%."
]